The goal of this study is to assess the clinical significance of TCF3 in human CRC, and to investigate mechanisms mediating overexpression of TCF3, which assist in early identifying a high-risk recurrence subset of the patients with stage II and III CRC. The gene discussed is TCF3; the disease is colorectal carcinoma.